CMML
Showing 176 - 200 of 200
Chronic Myelomonocytic Leukemia Trial in Austria (Revlimid)
Unknown status
- Chronic Myelomonocytic Leukemia
-
Linz, Oberösterreich, Austria
- +9 more
Mar 6, 2015
Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic Trial in France, United States
Completed
- Leukemia, Myelocytic, Acute
- +3 more
- Tacrolimus
- +2 more
-
Duarte, California
- +23 more
Feb 8, 2016
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Kashiwa, Tokyo (Oral azacitidine)
Terminated
- Myelodysplastic Syndromes
- +5 more
- Oral azacitidine
-
Kashiwa, Chiba, Japan
- +2 more
Jul 24, 2015
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Houston (Clofarabine)
Completed
- Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Oct 8, 2015
Chronic Myelomonocytic Leukemia Trial in France (Decitabine)
Completed
- Chronic Myelomonocytic Leukemia
-
Le Kremlin-BicĂȘtre, Ile de France, France
- +30 more
Mar 19, 2014
Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) Trial in Durham (WT1
Terminated
- Acute Myelogenous Leukemia (AML)
- +4 more
- WT1 derived peptides
-
Durham, North CarolinaDuke Comprehensive Cancer Center
Dec 7, 2013
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Denmark, Norway, Sweden (Azacitidine, Erythropoetin)
Completed
- Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
-
Aalborg, Denmark
- +16 more
Oct 28, 2013
Leukemia Trial in Leeds, Glasgow (azacitidine, laboratory biomarker analysis)
Completed
- Leukemia
- azacitidine
- laboratory biomarker analysis
-
Leeds, England, United Kingdom
- +1 more
Aug 23, 2013
Myelodysplastic Syndrome Trial in Houston (AR-67 (20S)-7-t-Butyldimethylsilyl-10-hydroxycamptothecin))
Unknown status
- Myelodysplastic Syndrome
- AR-67 (20S)-7-t-Butyldimethylsilyl-10-hydroxycamptothecin)
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jun 23, 2014
Leukemia Trial in Houston (3 Day Thiarabine, 5 Day Thiarabine)
Completed
- Leukemia
- 3 Day Thiarabine
- 5 Day Thiarabine
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 16, 2014
Chronic Myelomonocytic Leukemia, Previously Treated MDS, Recurrent Adult Acute Myeloid Leukemia Trial in Houston (liposomal
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- liposomal daunorubicin citrate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
MDS Trial in Tampa (Dasatinib)
Completed
- Myelodysplastic Syndromes
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 21, 2013
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloproliferative Disorders Trial in Houston (Hum-195/rGel)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Apr 1, 2013
Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia Trial in Houston (DTGM)
Terminated
- Acute Myelogenous Leukemia
- Chronic Myelomonocytic Leukemia
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
Feb 20, 2012
Myelodysplastic Syndrome Trial in United States (decitabine (5-aza-2'deoxycytidine))
Completed
- Myelodysplastic Syndrome
- decitabine (5-aza-2'deoxycytidine)
-
Berkeley, California
- +23 more
Jan 22, 2013
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia Trial in Houston (Bendamustine)
Terminated
- Acute Myeloid Leukemia
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 3, 2012
Chronic Myelogenous Leukemia, Multiple Myeloma, Non Hodgkin's Lymphoma Trial in Houston (CD8 Depleted Donor Lymphocyte)
Terminated
- Chronic Myelogenous Leukemia
- +4 more
- CD8 Depleted Donor Lymphocyte
-
Houston, TexasUT MD Anderson Cancer Center
Aug 22, 2012
Hematological Disease, Lymphoid Malignancies Trial in Belgium, France, Netherlands (CHR-2845)
Completed
- Hematological Disease
- Lymphoid Malignancies
-
Antwerp, Belgium
- +3 more
Nov 25, 2011
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in London (Decitabine)
Unknown status
- Acute Myeloid Leukemia
- +2 more
-
London, United KingdomKing's College Hospital NHS Foundation Trust
Sep 2, 2010
Biological Data With Potential Prognostic Relevance in
Unknown status
- Myelodysplastic Syndrome
-
Coppito, L'Aquila, Italy
- +13 more
Feb 7, 2011